BioTheranostics Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test The firm said that the expanded coverage provides more women with access to a test that helps determine whether extended endocrine therapy is appropriate. Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth Premium The company has invested revenues from its pandemic testing business to buy assets that are growing faster than its base business. Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines The expert body now recognizes the test's ability to predict whether early-stage breast cancer patients will benefit from extended, adjuvant endocrine therapy. Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Hologic said the acquisition of Biotheranostics will give it a company that operates in markets that are adjacent and complementary to its own. Hologic to Acquire Molecular Diagnostics Firm Biotheranostics for $230M Hologic said that Biotheranostics' PCR-based gene expression tests have been validated in large studies in areas of oncology with high growth potential. Apr 3, 2020 People in the News: Kim Popovits, Miles Harrison, Matt Sargent, More Sep 30, 2019 Carcinoma of Unknown Primary Investigators Pursue Molecular Targets to Tailor Treatments Premium Jun 13, 2019 ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer Premium Mar 5, 2019 Biotheranostics Breast Cancer Test Receives Expanded Medicare Coverage Determination Apr 20, 2018 Biotheranostics Settles False Claims Allegations With DOJ for $2M Dec 13, 2016 Breast Cancer Prognostic Test Comparison Considers Strengths, Weaknesses of Different Signatures Premium Sep 23, 2016 Biotheranostics, Syapse Ink Agreement to Offer Integrated Diagnostics Solution for Cancer Jan 21, 2016 BioMérieux Reports Sales Increases for Q4, FY15 Jan 21, 2016 BioTheranostics Raises $32M in Private Equity Financing; Will Spin Off From BioMérieux Oct 6, 2015 BioTheranostics, DeNovo Partner for CTC Proof of Concept Studies Oct 15, 2014 BioTheranostics Gets Medicare Coverage for Breast Cancer Index Test Oct 8, 2014 People in the News: Nicolas Barthelemy, Richard Ding, Bruce Bodaken, Karin Eastham, Jorge Garces Premium Sep 24, 2014 BioTheranostics Publishes BCI Cost Study; Suggests Benefit of Optimizing Extended Hormonal Therapy Premium Jul 16, 2014 New York Approves BioTheranostics to Offer Breast Cancer MDx Jul 16, 2014 BioTheranostics Modeling Study Demonstrates Cost Effectiveness of CancerType ID Test Premium Jul 10, 2014 FedMed to Cover BioTheranostics Cancer MDx Tests Jul 2, 2014 Palmetto GBA Issues Three Draft LCDs on Multi-marker Tests; MolDx Lays out Review Criteria, Process Premium Apr 9, 2014 BioTheranostics Inks Contract with PPO Prime Health Services Apr 2, 2014 PPO Three Rivers to Cover BioTheranostics' Cancer Testing Services Feb 5, 2014 New Products: BioTheranostics' BioT3 Cancer Test; Natera's Expanded Panorama Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.